Valerie M. Carlberg, MD

Publications

• Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature.

  (Iriarte C, Yeh JE, Alloo A, Boull C, Carlberg VM, Coughlin CC, Lara-Corrales I, Levy R, Nguyen CV, Oza VS, Patel AB, Rotemberg V, Shah SD, Zheng L, Miller CH, Hlobik M, Daigneault J, Choi JN, Huang JT, Vivar KL.) Support Care Cancer. 2024 Aug 23;32(9):610 PMID: 39174797 08/23/2024

• Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins.

  (Tanaka R, Mrachek K, Arocho-Quinones E, Carlberg VM, Smith C, Kurzrock R, Deshmukh T.) JCO Precis Oncol. 2024 May;8:e2400055 PMID: 38781546 SCOPUS ID: 2-s2.0-85200505701 05/23/2024

• Infantile Hemangioma of the Breast: Long-Term Assessment of Outcomes.

  (Labow BI, Alshamekh SA, Carlberg VM, Zacur JL, Uihlein LC, Mulliken JB, Liang MG.) Plast Reconstr Surg Glob Open. 2024 Jan;12(1):e5506 PMID: 38196847 PMCID: PMC10773794 01/10/2024

• Preoperative n-BCA embolization in the resection of submandibular lymphatic malformations refractory to sclerotherapy treatment: A pilot case series.

  (Shum A, Beydoun AS, Khalifee E, Carlberg V, Plunk M, Chun R.) Int J Pediatr Otorhinolaryngol. 2023 May;168:111510 PMID: 37003014 SCOPUS ID: 2-s2.0-85151488542 04/02/2023

• A 12-year-old male with localized, pink, tender papules.

  (Davies OMT, Astle JM, Harker-Murray PD, Wanat KA, Carlberg VM.) Pediatr Dermatol. 2023 Mar;40(2):367-368 PMID: 36989164 SCOPUS ID: 2-s2.0-85151312384 03/30/2023

• A 14-year-old female with a well demarcated nodule on the wrist.

  (Kelly BG, Goeser LE, Plunk MR, Carlberg VM.) Pediatr Dermatol. 2023;40(5):943-945 PMID: 36973067 03/28/2023

• Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome.

  (Butala S, Phan S, Siegel DH, Carlberg V, Paller AS.) Pediatr Dermatol. 2023;40(4):735-737 PMID: 36709954 01/30/2023

• Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study.

  (Boull CL, Gardeen S, Abdali T, Li E, Potts J, Rubin N, Carlberg VM, Gupta D, Hunt R, Luu M, Maguiness SM, Moertel CL, Song H, Vivar KL, Coughlin C, Huang JT, Lara-Corrales I.) J Am Acad Dermatol. 2021 Jun;84(6):1554-1561 PMID: 32682884 07/20/2020

• Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy.

  (Carlberg VM, Davies OMT, Brandling-Bennett HA, Leary SES, Huang JT, Coughlin CC, Gupta D.) Pediatr Dermatol. 2021 Jan;38(1):18-30 PMID: 33378085 12/31/2020

• Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy.

  (Sous D, Armstrong AE, Huang JT, Shah S, Carlberg VM, Coughlin CC.) Pediatr Dermatol. 2021 Jan;38(1):8-17 PMID: 33170534 11/11/2020

• Utilizing immediate preoperative n-BCA in the resection of head and neck venous and lymphatic malformations.

  (Puccia R, Staricha K, Carlberg VM, Moe D, Chun R.) Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110388 PMID: 33152979 SCOPUS ID: 2-s2.0-85091260636 11/07/2020

• Fibrillin-1 in the Vasculature: In Vivo Accumulation of eGFP-Tagged Fibrillin-1 in a Knockin Mouse Model.

  (Charbonneau NL, Manalo EC, Tufa SF, Carlson EJ, Carlberg VM, Keene DR, Sakai LY.) Anat Rec (Hoboken). 2020 Jun;303(6):1590-1603 PMID: 31251835 06/30/2019